HPR82 Assessment of Supporting Evidence and Postmarketing Requirements for Therapeutic Indications With Real-Time Oncology Drug Review, 2018-2023
| Title: | HPR82 Assessment of Supporting Evidence and Postmarketing Requirements for Therapeutic Indications With Real-Time Oncology Drug Review, 2018-2023 |
|---|---|
| Authors: | Mooghali, M; Mohammad, A; Wallach, JD; Mitchell, AP; Ross, JS; Ramachandran, R |
| Source: | Value in Health ; volume 27, issue 6, page S208 ; ISSN 1098-3015 |
| Publisher Information: | Elsevier BV |
| Publication Year: | 2024 |
| Collection: | ScienceDirect (Elsevier - Open Access Articles via Crossref) |
| Document Type: | article in journal/newspaper |
| Language: | English |
| DOI: | 10.1016/j.jval.2024.03.1151 |
| Availability: | https://doi.org/10.1016/j.jval.2024.03.1151; https://api.elsevier.com/content/article/PII:S109830152401266X?httpAccept=text/xml; https://api.elsevier.com/content/article/PII:S109830152401266X?httpAccept=text/plain |
| Rights: | https://www.elsevier.com/tdm/userlicense/1.0/ ; https://www.elsevier.com/legal/tdmrep-license ; http://www.elsevier.com/open-access/userlicense/1.0/ |
| Accession Number: | edsbas.5CAFAE5B |
| Database: | BASE |